“epilepsy” Archives

in
Entry Author Date Location
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug 09/30/20 New York
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs 09/28/20 Boston
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs 05/04/20 Boston
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia 01/11/20 San Diego
Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy 12/02/19 San Diego
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago 08/26/19 San Diego
Stoke Therapeutics Upsizes IPO, Raises $142M for Dravet Drug R&D 06/18/19 Boston
Stoke Therapeutics Preps IPO to Bring Dravet Syndrome Drug to Clinic 05/24/19 Boston
FDA Refuses to Review Zogenix Seizure Drug, Says File Not Complete 04/08/19 San Francisco
Former Zavante Executive Tapped as Abide Therapeutics President 01/28/19 San Diego
With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO 10/23/18 Boston
Bloom Science Plans to Advance Microbial Treatment for Epilepsy 05/24/18 San Diego
Amgen Migraine Decision Looms, Maybe the Next Drug Price Fight, Too 05/16/18 National
Hunting For Pharma Deals, Ovid Bags Epilepsy Drug from Takeda 01/18/17 New York
GSK, Verily Team Up For Electro-Implants That Monitor, Treat Patients 08/02/16 San Francisco
With Positive Postpartum Results, Sage Ponders More Mood Disorders 07/12/16 Boston
Four Years After Neuronex Buyout, Acorda Dumps Epilepsy Drug 05/20/16 New York
Tour of Texas: Cancer Moonshot, Lumos, Robyn Metcalfe, & Esperance 04/07/16 Texas
Lumos Pharma Raises $34M to Fund Clinical Trials for CTD Drug 04/06/16 Texas
Pronutria, Eyeing Clinical Push, Gets $42.5M From Nestle Health 02/23/16 Boston
Sharpening Its Focus On Drugs, Pronutria Bags $39M From Fidelity, Flagship 05/28/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
Page 1 of 2 next page »